Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Elemental iodine or iodine compound
Reexamination Certificate
2005-06-07
2005-06-07
Pak, John (Department: 1616)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Elemental iodine or iodine compound
C424S667000, C424S669000, C424S670000, C424S671000, C424S672000, C514S738000, C422S029000, C422S037000
Reexamination Certificate
active
06902747
ABSTRACT:
A teat dip composition comprising from about 0.1% to about 2% iodine by weight of the composition on a formulation basis and from about 50% to about 99.9% propylene glycol by weight of the composition on a formulation basis, and a method of using such composition to treat mastitis.
REFERENCES:
patent: 2863798 (1958-12-01), Shelanski et al.
patent: 3728449 (1973-04-01), Cantor et al.
patent: 3764669 (1973-10-01), Santorelli
patent: 4012504 (1977-03-01), Eckols
patent: 5919471 (1999-07-01), Saferstein et al.
patent: 6699907 (2004-03-01), Dee et al.
patent: 0 094 219 (1983-11-01), None
patent: WO 00/13560 (2000-03-01), None
patent: WO 02/28180 (2002-04-01), None
Chemical Abstracts 44:11018i-11019a, 1950.
Kirk-Othmer Encyclopedia of Chemical Technology, 4thedition, John Wiley & Sons, NY, 1993, vol. 8, p. 244.
Pending U.S. Appl. No. 08/602,498, Fatty Acid Antimicrobial, filed Feb. 20, 1996.
Pending U.S. Appl. No. 09/586,860, Fatty Acid Antimicrobial, filed Jun. 5, 2000.
Settlement Agreement executed on Dec. 18, 2001 and Jan. 3, 2002, 5pgs, and a related addendum.
Responses to Defendant, Westfalia-Surge, Inc.'s, First Set of Requests for Production of Documents to Plaintiff, Dr. Gardner, Oct. 29, 2001, 6pgs.
Answers to Defendant, Westfalia-Surge, Inc.'s, First Set of Interrogatories to Plaintiff, Dr. Gardner, Oct. 29, 2001, 7pgs.
Responses to Defendant, Westfalia-Surge, Inc.'s, First Set of Requests for Admissions, Oct. 29, 2001, 8pgs.
Form PCT/ISA/220, Notification of Transmittal of the International Search Report or the Declaration received Oct. 10, 2001, 6pgs.
Letter to Jeffry W. Smith from Craig T. Kenworthy, Sep. 5, 2001, 1pg.
Letter to Jeffry W. Smith from Craig T. Kenworthy, Aug. 21, 2001, 2pgs.
Letter to Craig T. Kenworthy from Jeffry W. Smith, Aug. 15, 2001, 2pgs.
Letter to Craig T. Kenworthy from Jeffry W. Smith, Aug. 2, 2001, 2pgs.
Letter to Jeffry W. Smith from Craig T. Kenworthy, Aug. 1, 2001, 2pgs.
Petition for Breach of Contract (w/o exhibits), filed Mar. 19, 2001, 11pgs.
Letter to Jeffry W. Smith from Jeffrey L. Groves, Jan. 19, 2001, 2pgs.
Letter to Jeffrey L. Groves from Jeffry W. Smith, Jan. 5, 2001, 3pgs.
Letter to Jeffrey L. Groves from Jeffry W. Smith, Dec. 20, 2000, 1pg.
Letter to Dale Termunde from Jeffrey L. Groves, Dec. 14, 2000, 2pgs.
Berkelman et al., “Increased Bacterial Activity of Dilute Preparations of Povidone-Iodine Solutions,” Journal of Clinical Microbiology, vol. 15:4, pp. 635-639, 1982.
Pankey et al., “Uptake on Postmilking Teat Antisepsis,” Journal of Dairy Science, vol. 67:6, pp. 2281-2288, 1984.
Fox et al., “Staphylococcus aureusColonization of Teat Skin as Affected by Postmilking Teat Treatment When Exposed to Cold and Windy Conditions,” Journal of Dairy Science, vol. 77:8, pp. 1336-1353, 1994.
Form PCT/IPEA/416, Notification of Transmittal of International Preliminary Examination Report, Aug. 27, 2003, 7 pgs.
Dee Alejandro O.
Gradle Charles D.
Pak John
Smith Law Office
Westfalia-Surge, Inc.
LandOfFree
Iodine-propylene glycol teat dip does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Iodine-propylene glycol teat dip, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Iodine-propylene glycol teat dip will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3513532